Agilon Health’s $2 Billion Secondary Offering and Repurchase of Common Stock

Debevoise & Plimpton LLP has advised agilon health (NYSE: AGL) and Clayton, Dubilier & Rice in the transaction.The transaction consiste in the secondary offering of approximately…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here